Treatment With Lopinavir/Ritonavir or Interferon-β1b Improves Outcome of MERS-CoV Infection in a Nonhuman Primate Model of Common Marmoset
Jasper Fuk‐Woo Chan(Hong Kong Science and Technology Parks Corporation), Kwok‐Yung Yuen(University of Hong Kong - Shenzhen Hospital), Hin Chu(University of Hong Kong), Jian‐Piao Cai(University of Hong Kong), Linlin Bao(Chinese Academy of Medical Sciences & Peking Union Medical College), Wei Deng(Wuhan Institute of Virology), Yanfeng Yao(Chinese Academy of Medical Sciences & Peking Union Medical College), Chuan Qin(Chinese Academy of Medical Sciences & Peking Union Medical College), Man Lung Yeung(Hong Kong Science and Technology Parks Corporation), Honglin Chen(University of Hong Kong), Pin Yü(Chinese Academy of Medical Sciences & Peking Union Medical College), Hong Gao(Institute of Laboratory Animal Science), Chong Xiao(Chengdu University of Traditional Chinese Medicine), Jie Zhou(Chinese University of Hong Kong), Fengdi Li(Institute of Laboratory Animal Science), Lilong Jia
Cited by 623
Related Papers
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
|The Lancet|2020|51.8k
A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster
|The Lancet|2020|9.6k
Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study
|The Lancet Infectious Diseases|2020|3.4k
Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan
|Emerging Microbes & Infections|2020|3.3k